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ABSTRACT
CHRONIC ETHANOL EXPOSURE SENSITIZES THE LUNG
IN A MOUSE MODEL OF ENDOTOXEMIA-INDUCED ACUTE LUNG INJURY:
POTENTIAL ROLE OF PLASMINOGEN ACTIVATOR INHIBITOR-1
Lauren G. Poole
July 22, 2015

The goal of this project is to characterize a new mouse model of alcoholenhanced acute lung injury (ALI) and to determine the role of plasminogen
activator inhibitor-1 (PAI-1) in this model. Male mice (WT and PAI-1-/-) were
exposed to ethanol-containing Lieber-DeCarli diet or pair-fed control diet for 6
weeks; some animals were administered intraperitoneal lipopolysaccharide (LPS)
prior to sacrifice. Chronic alcohol feeding enhanced induction of the chemokines
MIP-2 and KC (murine IL-8 homologues) after LPS injection in wild type animals.
This enhanced chemokine expression did not correlate with enhanced pulmonary
neutrophil infiltration, however animals exposed to chronic ethanol showed
sustained alveolar septal thickening and enhanced 4-HNE staining, indicative of
inflammatory damage. Septal thickening was completely attenuated in PAI-1-/animals. This work has developed a new mouse model which can be used to
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elucidate the mechanisms of alcohol-enhanced ALI. A potential role of PAI-1 in
alcohol-enhanced ALI has also been identified.
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INTRODUCTION
Alcohol consumption is a common custom worldwide. In the United States
alone, 87.6% of adults report consuming alcohol at some point in their lives (1).
Moreover, over 17 million Americans have been diagnosed with an alcohol use
disorder (1). This widespread consumption of alcohol continues despite the fact
that the detrimental health effects of alcohol abuse are well-established. In fact,
alcohol is known to contribute to the development of over 200 disease states (2),
making alcohol the fifth leading risk factor for premature death and disability
worldwide (3). The medical expenses for alcohol-related disease, combined with a
loss in productivity, are estimated to cost the U.S. government around 223.5 billion
dollars annually (4). Outside of lifestyle modification and treatment of secondary
sequelae (e.g., decompensation in liver disease), treatment options to halt or
reverse alcohol-related organ damage are limited. Moreover, despite increased
understanding of alcohol dependence, over 90% of alcoholics will relapse at least
once over a four year treatment period (5), meaning that the treatment of
alcoholism is not always a viable option for preventing the negative health effects
associated with alcohol abuse; this makes treatment of alcohol-related
pathophysiology a critical target for investigation. Therefore, there is an urgent
need to determine the mechanisms leading to alcohol-related organ injury in order
to identify new targets to prevent or reverse disease progression.
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The lung is recognized as a target of chronic alcohol abuse, and alcoholrelated lung injury is estimated to account for tens of thousands of deaths in the
United States each year (6). Although chronic alcohol consumption is not directly
linked to the development of lung disease (i.e., as it is to liver disease) alcohol is
a significant risk factor in the morbidity/mortality of lung damage from other causes.
For example, acute respiratory distress syndrome (ARDS), the most severe form
of acute lung injury (ALI), occurs 3.7 times more often in people meeting the
diagnostic criteria for alcohol use disorders (7, 8). Furthermore, Moss and
colleagues demonstrated that chronic alcoholics who developed ARDS showed inhospital mortality rates of 65%, whereas nonalcoholic patients had mortality rates
of 36% (7-9). The exact mechanisms by which alcohol mediates these effects on
the lung are unknown, but experimental alcohol consumption has been associated
with the up-regulation of pro-inflammatory cytokines (10-12), disruption of
regulatory signaling pathways (13), activation of tissue remodeling (14, 15), and
the induction of oxidative stress in rodent lungs (16). These factors contribute to
the development of an “alcoholic lung” phenotype. This phenotype appears to
enhance the host’s susceptibility to serious lung diseases, including ARDS, ALI
following severe trauma (e.g. car accident, gun shot, etc.), and respiratory infection
(e.g., pneumonia) (6).

Therefore, the primary goal of the current work is to

investigate the mechanisms by which chronic alcohol sensitizes the lung to injury
and inflammation.
Intraperitoneal (i.p.) injection of bacterial lipopolysaccharide (LPS), or
endotoxemia-induced lung injury, is a common animal model employed to study
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ALI and ARDS (17, 18). Indeed, this model has been demonstrated to cause
sequestration of neutrophils in the pulmonary vasculature and interstitium (19, 20).
Furthermore, i.p. LPS administration has been demonstrated to cause pulmonary
edema, diffuse alveolar damage, and induction of inflammatory cytokines and
chemokines, such as IL-6 and MCP-1 (21). Systemic administration of LPS (versus
intratracheal) is a particularly relevant model to investigate mechanisms of alcoholinduced organ pathology. In fact, chronic alcohol consumption has been
demonstrated to increase systemic LPS in patients (22), and this could in turn
damage the lung. Furthermore, although intratracheal administration of LPS has
been demonstrated to cause a large influx of PMNs into the alveoli, there are
concerns that this model may include confounding factors, such as aspiration injury
(20).

Others have demonstrated that chronic alcohol exposure enhances

glutathione depletion and oxidative stress in a rat model of endotoxemia-induced
ALI (16, 23). The effect of chronic alcohol exposure on endotoxemia-induced lung
injury and inflammation in a mouse model has not been tested. The first goal of
the current project is to characterize a mouse model of alcohol-enhanced acute
lung injury.
A major focus of the Arteel group’s recent research has been to investigate
parallel and possibly interdependent mechanisms of liver and lung injury in the
setting of chronic alcohol abuse. One proposed parallel mechanism of alcoholinduced liver and lung injury is the induction of tissue remodeling. The activation
of the coagulation cascade is a key response to acute injury which transiently alters
the extracellular matrix (ECM). Plasminogen activator inhibitor-1, or PAI-1, is a key
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regulator of the coagulation cascade. PAI-1 is an acute phase protein normally
expressed by adipocytes and endothelial cells, but is also expressed by other cells
during times of inflammation and/or stress (24). This group has identified a critical
role of PAI-1 in the progression of alcohol-induced liver injury. Specifically,
knocking out PAI-1 produced potent anti-inflammatory effects in a chronic enteral
alcohol model (25). Similar effects have also been demonstrated in other models
of hepatic inflammation, including LPS-induced liver injury enhanced by partial
hepatectomy (26) or ethanol pre-exposure (27). PAI-1 is also known to contribute
to the development of ALI and ARDS (28, 29), and elevated PAI-1 in
bronchoalveolar lavage (BAL) fluid in patients with these conditions is associated
with increased mortality (30-32). PAI-1 induction has also been demonstrated to
enhance susceptibility to LPS-induced ALI in animal models (33). PAI-1 induction
also enhances ALI in a model of bleomycin-induced lung injury (34). Although the
role of PAI-1 has been studied in many models of lung injury, including cancer (35),
fibrosis (36), and ALI (37), the role of PAI-1 in alcohol-enhanced ALI remains
largely unknown. Therefore, the second goal of the current work is to determine if
PAI-1 is involved in alcohol-mediated pulmonary sensitization.
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MATERIALS AND METHODS
A. Animals and Treatments
Mice were housed in a pathogen-free barrier facility accredited by the
Association for Assessment and Accreditation of Laboratory Animal Care, and
procedures were approved by the University of Louisville’s Institutional Animal
Care and Use Committee.
At time of sacrifice, animals were anesthetized with ketamine/xylazine (100/15
mg/kg, i.p.). Blood was collected from the vena cava just prior to sacrifice by
exsanguination and citrated plasma was stored for further analysis. Prior to lavage
of the lungs, 10 mL of PBS was perfused through the heart to flush the pulmonary
vasculature of erythrocytes. Bronchoalveolar lavage (BAL) was performed by
flushing the lung two times with 400 μL sterile PBS. Cells in the BAL fluid (BALF)
were separated by centrifugation and removed from remaining BALF and fixed on
slides for further analysis (38). Portions of lung tissue were snap-frozen in liquid
nitrogen for later analysis or fixed in 10% neutral buffered formalin for subsequent
sectioning and mounting on microscope slides

Total RNA was immediately

extracted from fresh lung tissue using RNA-stat (Tel-Test, Austin, TX) and
chloroform: phenol separation (see RNA isolation Methods).
B. Chronic model of alcohol exposure
Eight

week

old

male

C57BL6/J

and

PAI-1

knockout

(B6.129S2-

Serpine1tm1Mlg/J: PAI-1−/−) mice were purchased from the Jackson Laboratory (Bar
5

Harbor, ME) and exposed to either ethanol-containing Lieber-DeCarli diet (Dyets,
Inc.) or iso-caloric control diet. During the exposure period, animals were housed
in pairs in shoebox cages in a room held at 75 ˚F. Diet was provided in vacuum
tubes and replaced between 4 and 5 pm daily. Both ethanol-fed animals and their
pair-fed counterparts received control diet for the first two days of liquid diet feeding
to allow acclimation to the liquid diet feeders. After 2 days of acclimation, ethanol
concentrations were increased incrementally over the course of three weeks
before reaching the highest ethanol concentration, 6% (vol/vol) for the final three
weeks of exposure. Ethanol concentrations in the ethanol-containing diets were
as follows: 0% for two days of acclimation, 1% for two days, 2% for two days, 4%
for one week, 5% for one week, and 6% for three weeks. Ethanol-containing diet
was provided ad libitum for the entire course of the study. Because of the relatively
high caloric content of ethanol, pair-fed control animals received an iso-caloric
control diet; the calories in the iso-caloric diet were matched by adding a calorieequivalent of maltose-dextrin. To account for the reduced food consumption of
ethanol-fed mice, pair-fed mice were given the volume of diet consumed by their
ethanol-fed counterparts the night before. At the conclusion of the feeding period,
the two diet groups were further separated into additional groups that received
either LPS (E. coli; 10 mg/kg i.p Sigma, St. Louis, MO) or vehicle (saline). Animals
were euthanized 4 or 24 h after LPS (or vehicle) injection.
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Figure 1

0%1% 2% 4%

5%

6%

6 Week EtOH Feeding

LPS
Sacrifice

4-24 h

Figure 1: Lieber-DeCarli model of chronic alcohol exposure and
experimental endotoxemia
Mice received ethanol-containing or isocaloric maltose-dextrin containing LieberDeCarli diet (see Materials and Methods) for six weeks and were injected with
LPS (10 mg/kg i.p.) or vehicle (saline) 4 or 24 hours prior to sacrifice.
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C. Clinical chemistry
Plasma activity levels of alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) were determined spectrophotometrically using standard
kits (Thermotrace, Melbourne, Australia).
D. Histology
1. General morphology
Formalin fixed, paraffin embedded lung tissue was cut at 5 μm and mounted on
charged glass slides.

Sections were deparaffinized with Citrisolv (Fisher,

Waltham, MA) and rehydrated through graded ethanol.
stained with hematoxylin and eosin (H&E).

Sections were then

After staining, samples were

dehydrated through graded alcohol, washed in Citrisolv and then mounted with
Permount (Fisher, Waltham, MA).
2. Scoring of septal thickening and alveolar hemorrhage
Twenty blinded photomicrographs per sample of hematoxylin and eosinstained paraffin embedded lung tissues were taken in successive fields at 400x
magnification and saved. Four randomly selected alveolar septa per photograph
were measured using the straight line tool on ImageJ software (39). Resulting
measurements are given as length of the straight line pixels and represented as
fold of control. As per guidelines established by the American Thoracic Society,
areas of the tissue that were underinflated during histological preparation were
avoided, as this may cause the septa to appear artificially thickened (17).
Additionally, septa directly adjacent to a blood vessel or airway were avoided, as
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these septa are normally thickened by collagen present in the peribronchovascular
bundle (17).
Alveolar hemorrhage was scored using twenty blinded photographs per
sample of hematoxylin and eosin-stained paraffin embedded lung tissues taken at
400x magnification. Each field was assessed for the presence of alveolar
hemorrhage. Fields in which 0% of the tissue was hemorrhagic received a score
of 0. Those with 1-25% hemorrhagic tissue received a score of 1, 26-50% received
a score of 2, 51-75% received a score of 3, and 76-100% received a score of 4.
The average score of 20 fields is reported.
3. Neutrophil accumulation
Neutrophil accumulation in lung tissue was measured using chloracetate
esterase (CAE) staining. Briefly, formalin fixed, paraffin embedded lung tissue was
cut at 5 μm and mounted on charged glass slides. Sections were deparaffinized
with Citrisolv (Fisher, Waltham, MA) and rehydrated through graded ethanol.
Tissue specimens were incubated in a solution of napthol AS-D chloroacetate (1
mg/ml) in N,N-dimethylformamide, with 4% sodium nitrite and 4% new fuchsin. The
napthol AS-D chloroacetate is enzymatically hydrolyzed by chloroacetate esterase
in neutrophils, liberating the napthol compound. Napthol combines with a freshlyformed diazonium salt, leaving bright pink color deposits at the site of enzymatic
activity (University of Calgary Airway Inflammation Research Group).
4. Immunohistochemistry
Immunohistochemical staining for markers of macrophages (F4/80) and
oxidative stress (4-HNE) were performed as previously described (40). Briefly,
9

formalin-fixed, paraffin embedded sections (5 μm) were deparaffinized and
rehydrated with graded ethanol solutions. Endogenous peroxidase activity was
quenched by incubating slides in a 3% H2O2 solution for 5 minutes at room
temperature.
For F4/80 staining, slides were incubated in an avidin-biotin blocking reagent
(Dako, Carpinteria, CA) to reduce non-specific staining.

Then, slides were

incubated in primary antibody for the F4/80 cell surface receptor (1:50 in 10% goat
serum; Abcam, Cambridge MA) for two hours at room temperature.

The

Vectastain Elite ABC kit was used for detection (Vector Laboratories, Inc.,
Burlingame, CA). Briefly, tissue was incubated in a biotinylated anti-Rat IgG
secondary antibody for 15 minutes at room temperature. Tissue was then washed
and incubated in a solution containing avidin-bound horseradish peroxidase (HRP)
for 30 minutes.
4-HNE staining was detected using the UltraVision Detection System (Thermo
Scientific, Fremont, CA). Briefly, after hydrogen peroxide blocking, slides were
incubated in Ultra V Blocking Solution to reduce non-specific stain. Then, slides
were incubated in primary antibody for 4-HNE (1:500 in PBST+1% BSA, Alpha
Diagnostics, San Antonio TX) for 30 minutes at room temperature. For detection,
slides were incubated in biotinylated goat anti-Rabbit IgG secondary antibody for
10 minutes at room temperature. Tissues were then washed and incubated in a
solution containing avidin-bound horseradish peroxidase (HRP) for 10 minutes.
The HRP substrate 3, 3’-diaminobenzidine (DAB) was added to tissue sections
until positive (brown) staining was visible macroscopically.
10

Slides were

counterstained with Hematoxylin (Dako, Carpinteria, CA) for 1 minute, washed,
dehydrated through graded ethanol and then mounted with Permount (Fisher,
Waltham, MA). Each slide contained a negative tissue section which does not
receive primary antibody.
E. Myeloperoxidase Activity
Myeloperoxidase activity was measured as previously described (41, 42).
Frozen lung tissue samples were thawed and homogenized in 50 mM potassium
phosphate buffer (pH 6.0), then centrifuged at 9000 x g for 15 minutes at 4˚C.
Supernatant (containing hemoglobin) was discarded, and the resulting pellet was
resuspended in potassium phosphate buffer (pH 6.0) containing 50 mM
hexadecyltrimethylammonium bromide (HTAB) and homogenized again. This
suspension was sonicated, and snap frozen in liquid nitrogen and thawed for three
freeze-thaw cycles. Samples were then centrifuged at 9000 x g for 10 minutes at
4˚C. The resulting supernatant was then assayed spectrophotometrically for
myeloperoxidase activity in 50 mM potassium phosphate (pH 6.) with 0.0005%
hydrogen peroxide and 0.167 mg/mL o-dianisidine dihydrochloride (substrates of
myeloperoxidase) at 450 nm. Results are reported as rate of reaction per mg of
lung tissue.
F. RNA Isolation and Quantitative Reverse-Transcription Polymerase Chain
Reaction
Total RNA was extracted from lung tissue by a guanidinium thiocyanate-based
method (RNA STAT 60 Tel-Test, Ambion, Austin, TX). RNA concentrations were
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determined spectrophotometrically and 1µg of total RNA was reverse transcribed
using a kit (Quanta Biosciences, Gaithersburg MD).
The pulmonary mRNA expression of select genes was detected by quantitative
reverse-transcription polymerase chain reaction (qRT-PCR), which is routine for
this group (27). PCR primers and probes for TNF-α, PAI-1, IL-6, and IL-1β were
designed using Primer 3 (Whitehead Institute for Biomedical Research, Cambridge
MA). Primers and probes for ICAM-1, VCAM-1, PECAM (CD31), MIP-2, KC, F4/80,
MCP-1, MIP-1β, lungkine, and B-actin were purchased from Life Technologies. All
primers were designed to cross introns and ensure that only cDNA and not
genomic DNA was amplified. PerfeCta qPCR Fast Mix (Quanta Biosciences,
Gaithersburg MD) was used to prepare the PCR mixture. This 2X mixture is
optimized for TaqMan reactions and contains MgCl2, dNTPs, and AccuFast Taq
DNA Polymerase. Amplification reactions were carried out using the ABI StepOne
Plus machine and software (Quanta Biosciences, Gatithersburg, MD) with initial
holding stage (95˚C for 30 seconds) and 50 cycles of a 2-step PCR (95˚C for 30
seconds, 60˚C for 20 seconds). Fluorescent intensity of each sample was
measured at each cycle to monitor amplification of the target gene. The
comparative CT method was used to determine fold changes in mRNA expression
compared to an endogenous reference gene (B-actin). This method determines
the amount of target gene, normalized to an endogenous reference and relative to
a calibrator (2ΔΔCT).
G. Statistical Analyses
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Results are reported as means ± standard error (SEM; n = 3-6). ANOVA with
Bonferroni’s post-hoc test (for parametric data) or Mann-Whitney Rank Sum test
(for non-parametric data) was used for the determination of statistical significance
among treatment groups, as appropriate. A p value less than 0.05 was selected
before the study as the level of significance.
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RESULTS
Over the course of the six weeks of dietary exposure, ethanol-fed mice gained
3.2±0.4 g and pairfed mice gained 4.2±0.4 g. Ethanol feeding alone caused
elevated plasma transaminase (ALT and AST), as did four hours of LPS exposure;
however, these changes were not significant. Ethanol feeding significantly
enhanced ALT levels 4 hours after LPS injection when compared with pairfed
animals. AST levels were significantly elevated 24 hours after LPS injection in
pairfed and ethanol-fed animals. These results are summarized in Table 1.
1. Ethanol enhanced pulmonary damage caused by systemic administration
of LPS.
As expected, LPS administration caused pulmonary damage in the form of
alveolar hemorrhage and thickening of the alveolar septa (21). Hemorrhage
was seen as early as four hours after LPS as an increase in the number of red
blood cells in the pulmonary intersitium (Figure 2, middle panels). Hemorrhage
was macro-heterogeneous, with some areas of the pulmonary tissue
experiencing more severe hemorrhage than others. Scoring of blinded
photomicrographs (as described in Materials and Methods) revealed that
alcohol exposure had no significant effect on the amount or severity of alveolar
hemorrhage (Figure 3A). Significant thickening of the alveolar septa occurred
four hours after LPS injection, as seen in H&E staining (Figure 2, middle
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Table 1

Pairfed
+ LPS (4h)
+ LPS (24h)
EtOH
+ LPS (4h)
+ LPS (24h)

Body
Weight (g)

Weight Gain
(g)

25.8±0.5

4.2±0.4

EtOH
Consumption
(g/day)
N/A

26.2±0.6

3.2±0.4

0.454±0.004

ALT

AST

22±3
45±2
153±57
47±3
99±19b
110±33

32±3
70±7
155±30a
51±15
95±16
172±26a

Table 1: Routine parameters and clinical chemistry
Data are presented as mean±SEM. a, p < 0.05 compared to pairfed controls;
b, p < 0.05 compared to LPS alone
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panels). Twenty-four hours after LPS injection, alveolar walls resembled that of
control animals in pairfed animals (Figure 2, bottom left panel); conversely,
alveolar walls in ethanol fed animals doubled in thickness at this time point
(Figure 2, bottom left panel). Measurements of alveolar septa in blinded
photomicrographs reveal that these differences are statistically significant
(Figure 3B).
2. Ethanol did not affect recruitment of neutrophils or macrophages to the
lung after LPS injection.
Because ALI is associated with robust neutrophil infiltration into the
pulmonary interstitium (43), the effects of alcohol on pulmonary neutrophil
recruitment were assessed histologically and enzymatically. As expected, LPS
injection caused a robust increase in the number of neutrophils in the
pulmonary vasculature and interstitium, as indicated by an increase in the
number of pink CAE-positive cells (Figure 4, left panel). This histological
observation was associated with an increase in MPO activity (Figure 5A).
Ethanol feeding did not significantly affect neutrophil recruitment compared to
pairfed counterparts.
Resident macrophages in many tissues, including in the lung, are often
involved in inflammatory tissue damage. To determine if alcohol-enhanced
pulmonary damage was caused by an increase in the number of alveolar
macrophages, the number of alveolar macrophages was determined using
immunohistochemical staining for the macrophage surface marker F4/80.
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Figure 2

EtOH

24h LPS

4h LPS

Control

Pairfed

Figure 2: Effects of chronic alcohol on pulmonary injury after LPS
injection.
Representative photomicrographs of lung tissue after hematoxylin and eosin
staining (400x, H&E).
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Figure 3

A
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Figure 3: Effects of chronic alcohol feeding on indices of pulmonary
damage.
Alveolar hemorrhage (A) was scored in blinded H&E-stained photomicrographs
and septal thickness (B) was measured as described in Materials and Methods.
Indices are reported as mean ± SEM. a, p < 0.05 compared to pairfed controls;
b, p < 0.05 compared to LPS alone; c, p < 0.05 compared to 4h LPS.
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Histologically, LPS injection appeared to cause an increase in the number of
F4/80-positive cells (Figure 4, right panel). Ethanol feeding did not have a
significant effect on the number of F4/80 cells compared to LPS alone. This
increase in F4/80-positive cells seen with LPS did not, however, correlate with
an increase in F4/80 mRNA expression (Figure 5B).
3. Alcohol exposure enhances expression of a subset of pro-inflammatory
mediators.
Acute lung injury is characterized by increased expression of several
inflammatory mediators (17, 21). The effect of chronic alcohol feeding on the
pulmonary inflammatory expression profile was determined using qRT-PCR
(as described in Materials and Methods). Ethanol alone had no significant effect
on expression of any inflammatory mediators measured, including TNFα, IL-6,
IL-1β, or PAI-1 (Figure 6A). LPS injection significantly induced expression of
these four mediators. Ethanol feeding significantly enhanced expression of the
inflammatory cytokine IL-6. Expression of TNFα, IL-1β, and PAI-1 after LPS did
not significantly change in animals exposed to chronic ethanol.
Because chemokines and subsequent neutrophil recruitment are known to
play a key role in ALI (44), the expression of several chemokines were also
determined (Figure 6B). Once again, ethanol feeding alone did not significantly
alter expression of any of the chemokines measured, including MCP-1, MIP1β, lungkine, MIP-2, and KC. LPS significantly induced expression of MCP-1,
MIP-1β, MIP-2, and KC and significantly decreased lungkine expression.
Alcohol feeding did not significantly affect expression of MCP-1, MIP-1β, or
19

Figure 4

F4/80

EtOH

24 hr LPS

Pairfed

Control

CAE

Figure 4: Effect of chronic alcohol feeding on pulmonary infiltration of
neutrophils and macrophages.
Representative photomicrographs of paraffin-embedded lung tissue samples
stained for CAE (left) and F4/80 (right) as described in Materials and Methods
(400X). CAE- and F4/80-positive cells are indicated with arrows in insets.
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Figure 5
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Figure 5: Effect of chronic alcohol feeding on myeloperoxidase (MPO)
activity and F4/80 mRNA expression.
MPO activity (A) and F4/80 mRNA expression (B) were determined as
described in Materials and Methods. Data are reported as mean ± SEM. a, p <
0.05 compared to pairfed controls.
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Lungkine after LPS. In contrast, alcohol feeding significantly enhanced
expression of MIP-2 and KC after LPS.
Finally, expression of several adhesion molecules involved in leukocyte
migration were measured, including ICAM-1, VCAM-1 and PECAM (Figure
6C). In a similar pattern to other inflammatory mediators measured, alcohol
feeding alone had no significant effect on expression of adhesion molecules.
LPS injection alone significantly increased expression of ICAM-1 and VCAM1, but significantly decreased expression of PECAM. Ethanol feeding
significantly enhanced expression of ICAM-1 and VCAM-1, but did not affect
PECAM expression after LPS.
4. Ethanol feeding enhanced oxidative stress after LPS injection.
Others have shown that alcohol feeding causes glutathione depletion and
oxidative stress in the lung (16). To determine the effect of chronic alcohol on
oxidative

stress

in

this

model,

lung

tissues

were

stained

immunohistochemically for the oxidative stress marker, 4-hydroxynonenol (4HNE; Figure 7). As demonstrated by an increase in the amount of positive
brown staining, ethanol feeding alone caused increased oxidative stress. LPS
injection alone caused a similar increase in 4-HNE staining. Ethanol feeding
increased both the amount and intensity of 4-HNE staining after LPS injection.
5. PAI-1 deficient animals are protected against alcohol-enhanced lung
injury.
To determine the involvement of PAI-1 in this model of alcohol-enhanced
acute lung injury, PAI-1 knockout mice were fed an ethanol-containing liquid
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Figure 6: Effect of chronic alcohol feeding on LPS-induced expression of
inflammatory mediators
The effects of alcohol feeding on expression of inflammatory mediators (A),
chemokines (B), and adhesion molecules (C) were measured as described in
Materials and Methods. Data are reported as mean ± SEM. a, p < 0.05
compared to pairfed controls; b, p < 0.05 compared to LPS alone.
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Figure 7

Figure 7: Effects of chronic alcohol feeding on oxidative stress after LPS
injection (4 h).
Oxidative stress was assessed immunohistochemically in paraffin-embedded
lung tissues using an antibody against the marker 4-HNE, as described in
Methods and Materials. Representative photomicrographs are shown (400X).
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diet for 6 weeks (as described in Materials and Methods). Ethanol-fed control
PAI-1-/- animals showed no significant differences in alveolar septal thickness
compared with ethanol-fed wild-type animals or pairfed wild-type animals. As
previously demonstrated, chronic alcohol feeding cause significant septal
thickening 24 hours after LPS administration. On the other hand, this septal
thickening was significantly attenuated in PAI-1 knockout animals (Figures 8A
and 8B). Additionally, as demonstrated previously, chronic alcohol feeding
enhanced expression of the chemokines MIP-2 and KC, and the inflammatory
cytokine IL-6. Enhanced IL-6 expression was blunted, albeit not significantly, in
PAI-1 knockout animals. Ethanol-enhanced MIP-2 and KC expression were
significantly attenuated in PAI-1 knockout animals. (Figure 8C).
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Figure 8: Effect of PAI-1 deletion on indices of alcohol-enhanced ALI
Representative photomicrographs of H&E-stained lung tissue sections (400X,
A), expression of inflammatory mediators measured by qRT-PCR (B),
quantification of septal thickening (as described in Materials and Methods) (C).
a, p < 0.05 compared to pairfed controls; b, p < 0.05 compared to LPS alone; c,
p < 0.05 compared to 4h LPS; d, p < 0.05 compared to WT animals
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DISCUSSION
Although chronic alcohol abuse does directly cause overt lung pathology,
alcohol is known to increase susceptibility to severe lung injury, such as acute
respiratory distress syndrome (ARDS) (7, 8).Therefore, the primary goal of this
work was to characterize the effects of chronic alcohol exposure on inflammation
and injury in a mouse model of acute lung injury in experimental endotoxemia
utilizing systemically administered LPS. In accordance with previous studies (16,
21), experimental endotoxemia caused pulmonary injury, as evidenced by alveolar
hemorrhage and septal thickening indicative of pulmonary edema. Chronic ethanol
exposure did not affect the presence or severity of alveolar hemorrhage, but
chronic ethanol did enhance and prolong septal thickening. These data are similar
to findings by Holguin and colleagues, who determined that ethanol enhanced
edematous lung injury in a rat model of ethanol pre-exposure and experimental
endotoxemia (16). These data suggest that chronic alcohol exposure sensitizes
the lung parenchyma to enhanced inflammatory damage.
In this model, chronic alcohol feeding had specific effects on the pulmonary
inflammatory response after LPS. Alcohol alone did not cause a generalized
increase in expression of pro-inflammatory mediators; instead, alcohol enhanced
LPS-induced expression of a specific set of inflammatory mediators, including
cytokines, chemokines, and adhesion molecules. One of these mediators was the

27

cytokine, IL-6. IL-6 is a pleotropic cytokine that is widely accepted to be involved
in the acute phase response (45). Interestingly, IL-6 has been shown to have both
pro- and anti-inflammatory properties (45). In fact, expression of adhesion
molecules, including ICAM-1 and VCAM-1 has been demonstrated to be induced
by IL-6 signaling, leading to enhanced neutrophil infiltration into target tissues (45,
46). Moreover, STAT3, which is activated by IL-6 has been shown to be critically
involved in acute lung inflammation in a model of Streptococcus infection (47).
Inhibition of STAT3 caused a dramatic decrease in M1-protein induced pulmonary
edema, MPO activity, and CXC chemokine production.
On the other hand, IL-6 is an important cytokine in the resolution of
inflammation. IL-6 is also known to be involved in the transition from the innate to
the adaptive immune response, particularly the switch away from neutrophil
recruitment to monocyte recruitment (48). Moreover, IL-6 drives differentiation of
monocytes to macrophages. Others have shown that IL-6 knockout mice have
enhanced pulmonary neutrophil recruitment, MIP-2 expression, TNF-α expression,
and mortality in a model of LPS-induced acute lung injury (49). This thesis
demonstrated that alcohol feeding drastically enhanced IL-6 expression after
systemic LPS administration.

This enhanced expression may be involved in

increased neutrophil chemotaxis through the upregulation of the adhesion
molecules ICAM and VCAM, as well as through the STAT3-mediated production
of the CXC chemokines MIP-2 and KC. Conversely, enhanced IL-6 expression
may be a compensatory mechanism involved in the resolution of alcohol-enhanced

28

inflammation. These opposing effects make IL-6 an interesting target for future
study in this model of alcohol-enhanced ALI.
A hallmark of ARDS is a robust increase in the expression of the potent
neutrophil chemoattractant, IL-8 (20). IL-8 has a well-defined role in ALI and ARDS
through the recruitment and activation of neutrophils, and increased levels of IL-8
in the BALF of patients has been associated with an increased risk of developing
ARDS, as well as increased mortality (44). In this model of alcohol-enhanced acute
lung injury, chronic alcohol consumption enhanced expression of the murine IL-8
homologues, MIP-2 and KC. Although chronic alcohol robustly enhanced MIP-2
and KC expression caused by LPS, there was not an associated increase in
recruitment of inflammatory cells, including macrophages and neutrophils. This
suggests that while the number of neutrophils is unchanged, neutrophils in alcoholfed animals may show increased activation, and therefore, increased tissue
damage.
In fact, a marker of neutrophil activation is the generation of reactive oxygen
species (ROS) for the killing and phagocytosis of pathogens- a phenomenon
known as oxidative burst (50). Others have shown that IL-8 stimulation primes
neutrophils for oxidative burst in a dose-dependent manner (51), suggesting that
enhanced MIP-2 and KC expression (IL-8 homologues) may contribute to
enhanced pulmonary damage due to neutrophil-mediated oxidative stress. Indeed,
this work has demonstrated that chronic alcohol feeding causes enhanced
oxidative stress after LPS administration. Additionally, others have demonstrated
that oxidative stress itself can enhance IL-8 production (52). Previous work has
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demonstrated that alcohol administration causes oxidative stress in the lung via
glutathione depletion (16). The work presented in this thesis has confirmed this
finding in a murine model. These results suggest that alcohol, via the induction of
oxidative stress, primes macrophages to enhanced chemokine production after an
inflammatory stimulus, such as LPS. This enhanced IL-8 production (or MIP-2/KC
in rodents) may enhance the oxidative burst of recruited neutrophils, leading to
enhanced inflammatory damage of pulmonary tissues. This hypothesis is outlined
in Figure 9.
Finally, the current work has identified a potential novel role of PAI-1 in alcoholenhanced ALI. As mentioned previously, the Arteel group has identified a critical
role of PAI-1 in the development of alcohol-induced liver injury and inflammation
(26, 27). Indeed, PAI-1 knockout mice were protected against alcohol-induced liver
injury, inflammation, and necrosis in an enteral model of chronic alcohol exposure
(26). As mentioned previously, PAI-1 is also known to play a role in several models
of experimental ALI (33, 34, 37). Interestingly, in the model of alcohol-enhanced
ALI described here, PAI-1 expression was not significantly enhanced after LPS by
alcohol feeding, yet PAI-1 knockout animals were protected against enhanced
septal thickening and chemokine production. These results suggest that while PAI1 itself may not be directly involved, it is involved in critical pathways in the
development of alcohol-enhanced ALI. This makes PAI-1 a unique target for
further mechanistic investigation.
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Figure 9: Proposed scheme of alcohol-enhanced pulmonary inflammation
and injury
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SUMMARY AND CONCLUSIONS
Strengths of this work
This thesis has many strengths. First, it establishes and characterizes a
murine model of alcohol-enhanced ALI. Patients meeting the diagnostic criteria for
an alcohol use disorder are 3.7 times more likely to develop acute respiratory
distress syndrome (7, 8), suggesting that chronic alcohol sensitizes the lung to
injury. The effects of chronic alcohol exposure on the development of lung injury
have been investigated in other species (23), as well as in other models of alcohol
administration (e.g. in drinking water). The characterization of the mouse model
described in this work is particularly useful, however, because of the wide variety
of genetically modified strains readily available at relatively low cost compared to
other animal models.
Secondly, this work utilizes an in-vivo approach which accounts for the
interaction of many pathways and organ systems. In particular, alcohol-induced
organ pathology is complex, involving interactions between multiple organ
systems, including the gut and the liver. Systemically administered LPS is a
common model used to study ALI resulting from a systemic infection, and the
model used for these studies is considered particularly relevant because of its
ability to mimic sepsis-induced ALI (18). Intratracheal administration of LPS
induces a robust inflammatory response, but confounding factors, such as
aspiration injury, make it less applicable for the studies described in this thesis
(20).
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Additionally, these studies identified potential mechanisms by which alcohol
sensitizes the lung to injury and reveal potential targets for therapy for alcoholic
patients at risk for developing ARDS. Others have shown that alcohol
administration causes pulmonary glutathione depletion and oxidative stress (16,
23, 53). It is also known that oxidative stress enhances expression of IL-8 from
dendritic cells (52), which may then prime neutrophils to enhanced production of
reactive oxygen species (ROS). Indeed, this work demonstrates that chronic
alcohol exposure enhanced pulmonary oxidative stress after LPS administration.
Furthermore, enhanced oxidative stress caused by ethanol pre-exposure was
associated with enhanced alveolar septal thickening, a sign of tissue damage.
Other studies have shown that N-acetylcysteine (NAC), a glutathione precursor, is
protective in models of acute alcohol-induced liver injury (54). The lung is
dependent on liver-derived glutathione (23), and alcohol intoxication depletes
hepatic glutathione. Additionally, NAC has been shown to be protective in a model
of LPS-induced ALI (55). Pretreatment with NAC has been shown to protect
against hepatic glutathione depletion in mouse models (54), and may therefore
protect the lung during alcohol-enhanced ALI. NAC has been used in clinical trials
in alcoholic hepatitis in combination with other drugs with some effectiveness (56),
and has improved intracellular glutathione pools and patient outcome in ARDS
patients (57). Thus, it is possible that N-acetylcysteine could also protect the lung
during alcohol-enhanced ALI and should be investigated as a potential therapy in
future studies
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Finally, this work has identified a novel role of PAI-1 in mediating the
sensitizing effects of alcohol in the setting of acute lung injury. While PAI-1 is
known to play a role in other models of acute lung injury (33, 34, 37), its role in
alcohol-enhanced ALI has not been investigated. While the exact mechanism by
which PAI-1 is involved in alcohol-enhanced ALI remains unclear, this study
demonstrates that PAI-1 is critically involved in alcohol-enhanced chemokine
production and inflammatory damage (e.g. alveolar septal thickening). These
results introduce an interesting, novel target for future investigation.
Unanswered questions and future directions
What is the role of PAI-1 in alcohol-enhanced ALI?
The Arteel group has previously identified a critical role of PAI-1 in alcoholinduced liver injury and inflammation (26). Specifically, knocking out PAI-1
produced potent anti-inflammatory effects in a chronic enteral alcohol model (25).
Classically, PAI-1 is an inhibitor of tissue-type plasminogen activator and
urokinase-type plasminogen activator (tPA and uPA, respectively), thereby
preventing the conversion of plasminogen to plasmin. Plasmin is involved in the
coagulation cascade by degrading the extracellular matrix protein fibrin. Therefore,
PAI-1 plays a major role in regulating fibrinolysis. The Arteel group has also
demonstrated the critical role of PAI-1-induced fibrin accumulation in alcoholinduced liver injury (27). Ethanol pre-exposure enhanced LPS-induced fibrin
deposition in the hepatic sinusoidal space, and inhibiting fibrin deposition protected
against enhanced liver injury and inflammation.
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The work described in this thesis has identified PAI-1 as a key mediator in
alcohol-enhanced lung injury and chemokine production, despite the fact that PAI1 induction is not significantly enhanced by alcohol feeding. Future experiments
should determine the role of PAI-1 in alcohol-enhanced ALI, particularly the role of
PAI-1-mediated fibrin accumulation.
What is the role of ECM remodeling in alcohol-enhanced ALI?
One mechanism by which PAI-1 may contribute to alcohol-enhanced ALI is
by mediating ECM remodeling. In addition to its role in fibrinolysis, PAI-1 indirectly
regulates the expression of many other ECM proteins, including laminin,
proteoglycan, and type IV collagen via inhibition of matrix metalloproteinases
(MMPs) (58-61) (62). PAI-1 induction has also been shown to enhance fibronectin
ECM deposition (63). Many cell types, including alveolar macrophages, bind to
select ECM proteins under basal conditions, and cell surface receptors known as
integrins mediate crosstalk between the ECM and the cell (64). For example, fibrin
interacts with RGD-binding integrins, including integrin αVβ3. Previous work from
the Arteel group has demonstrated that blocking fibrin-integrin interactions protects
against alcohol-induced liver injury with no effect on fibrin accumulation (65),
suggesting that integrin αVβ3 signaling is critical for the progression of liver injury.
Alveolar macrophages bind with high affinity to fibronectin and vitronectin ECM via
the integrins α5β1 and αVβ3, respectively. Chronic alcohol exposure has been
shown to cause deposition of a fibronectin-enriched pulmonary ECM. PAI-1
induction can inhibit vitronectin-integrin interactions, impairing tissue repair (66).
Thus, changing the ECM substratum can alter integrin signaling, and subsequently
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the phenotype of the surrounding cells. For example, ligation of the integrin αVβ3
has been shown to enhance expression of pro-inflammatory cytokines via NFκB
activation (67), and α5β1-mediated macrophage binding to fibronectin can also be
pro-inflammatory (62). Future research will examine the role of PAI-1-mediated
ECM alterations, and how this altered ECM profile may affect integrin signaling,
and therefore, the inflammatory response.
Is the liver involved in alcohol-enhanced lung injury?
A recent focus of the Arteel group has been to investigate parallel, and
potentially interdependent mechanisms of liver and lung injury in the setting of
chronic alcohol exposure. For example, the current work has identified PAI-1
activity as a potential parallel mechanism of organ injury. Additionally, the work
presented here, and additional work from the Arteel group suggests that liverderived mediators (e.g. TNFα (68)) may be directly involved in alcohol-enhanced
lung inflammation. For example, the Arteel group has recently found that
administration of the TNFα-blocking drug, etanercept, prevented alcoholenhanced induction of MIP-2 and KC after LPS administration (Massey et. al.,
under review). Additionally, Siore and collaborators demonstrated a possible
interaction between the liver and lung in an in situ perfused piglet preparation (69).
This model revealed that hypoxemia and pulmonary edema were only observed
when the liver and lung circulations were connected. Their results indicate that
while endotoxemia could directly cause pulmonary vasoconstriction and leukocyte
sequestration, interaction between the liver and lung was required for severe
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inflammatory response and oxidative injury to the lung. Future research should
elucidate and solidify this potential link between the liver and the lung.
Lastly, PAI-1 is a known downstream target of TNFα signaling. Future
research should investigate the role of hepatic-derived TNFα in the induction and
activity of PAI-1 in this model of alcohol-enhanced ALI.
Conclusions
In conclusion, this thesis has established and characterized a mouse model
of alcohol-enhanced acute lung injury. It was determined that alcohol enhances
LPS-induced alveolar septal thickening, as well as LPS-induced pulmonary
expression of IL-6 and the murine IL-8 homologues MIP-2 and KC. These effects
were potentially mediated by oxidative stress. This thesis also identified PAI-1 as
a novel mediator of alcohol-enhanced pulmonary injury. This thesis is of interest
because it establishes a mouse model which can be used in future studies to
elucidate the mechanisms by which alcohol consumption sensitizes the lung to
further injury. Although this thesis has characterized many aspects of ALI, ALI is a
complicated disease state, and no single animal model is able to recapitulate all
clinical aspects of the disease. However, this model has proven useful for the study
of edematous injury and cytokine/chemokine production – two highly relevant
clinical markers of ARDS. This model will be useful in future studies, including
investigation of the role of PAI-1 and PAI-1-mediated ECM remodeling in alcoholenhanced pulmonary injury.
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ABBREVIATIONS
4-HNE

4-hydroxynonenol

ALI

Acute lung injury

ALT

Alanine transaminase

ARDS

Acute respiratory distress syndrome

AST

Aspartate transaminase

BAL

Bronchoalveolar lavage

BALF

Bronchoalveolar lavage fluid

CAE

Chloroacetate esterase

DAB

3, 3’-diaminobenzidine

EtOH

Ethanol

H&E

Hematoxylin and eosin

HTAB

Hexadecyltrimethylammonium bromide

ICAM-1

Intracellular adhesion molecule 1

IL-1β

Interleukin 1 beta

IL-6

Interleukin 6

IL-8

Interleukin 8

I.P.

Intraperitoneal

KC

Keratinocyte-derived chemokine

KO

Knockout

LPS

Lipopolysaccharide

MCP-1

Monocyte chemoattractant protein 1

MIP-1β

Macrophage inflammatory protein 1 beta
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MIP-2

Macrophage inflammatory protein 2

MPO

Myeloperoxidase

PAI-1

Plasminogen activator inhibitor one

PECAM

Platelet endothelial cell adhesion molecule

qRT-PCR

Quantitative reverse-transcription polymerase chain reaction

ROS

Reactive oxygen species

STAT3

Signal transducers and activators of transcription 3

TNFα

Tumor necrosis factor alpha

VCAM-1

Vascular cell adhesion molecule 1
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